In this interview, Dr. Marsh Durban explores how innovations such as controlled seeding and size‑selection are enabling researchers to generate uniform, assay‑ready organoids at scale.
Over the ensuing five hours, the NIH leadership and MAHA Institute moderators found many areas of common ground: anger over ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results